IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: Biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522)
The review underscores the therapeutic potential of microbiome-targeted treatments as a novel approach to managing GI disorders, offering personalized and alternative options to conventional therapies
Unfortunately, glutathione production tends to deplete as we age
Comparative laboratory investigations frequently evaluate spray formulations alongside lyophilized peptide preparations to better understand formulation behavior, stability profiles, analytical characteristics, and standardized laboratory handling procedures
Feeling awesome after
Patients who report a severe delayed immune-mediated reaction (e.g., drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome or toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug-induced nephritis or hepatitis) should subsequently avoid the culprit drug, as this can be regarded as a contraindication to future use